[go: up one dir, main page]

MX2017010883A - Composicion para el tratamiento de la infertilidad. - Google Patents

Composicion para el tratamiento de la infertilidad.

Info

Publication number
MX2017010883A
MX2017010883A MX2017010883A MX2017010883A MX2017010883A MX 2017010883 A MX2017010883 A MX 2017010883A MX 2017010883 A MX2017010883 A MX 2017010883A MX 2017010883 A MX2017010883 A MX 2017010883A MX 2017010883 A MX2017010883 A MX 2017010883A
Authority
MX
Mexico
Prior art keywords
infertility
treatment
composition
fsh
preparations including
Prior art date
Application number
MX2017010883A
Other languages
English (en)
Inventor
Carlos Arce Saez Joan
Helmgaard Lisbeth
Mirner Klein Bjarke
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Publication of MX2017010883A publication Critical patent/MX2017010883A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)

Abstract

Preparaciones que incluyen FSH, por ejemplo, FSH recombinante, para el uso en el tratamiento de la infertilidad.
MX2017010883A 2015-04-17 2016-04-15 Composicion para el tratamiento de la infertilidad. MX2017010883A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15164043 2015-04-17
PCT/EP2016/058358 WO2016166288A1 (en) 2015-04-17 2016-04-15 Composition for treatment of infertility

Publications (1)

Publication Number Publication Date
MX2017010883A true MX2017010883A (es) 2017-12-07

Family

ID=52997893

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017010883A MX2017010883A (es) 2015-04-17 2016-04-15 Composicion para el tratamiento de la infertilidad.

Country Status (17)

Country Link
US (3) US10660938B2 (es)
EP (2) EP3662925B1 (es)
JP (2) JP7079094B2 (es)
KR (2) KR20240073153A (es)
CN (1) CN107405385A (es)
AU (1) AU2016247498B2 (es)
CA (1) CA2975444A1 (es)
DK (2) DK3283097T3 (es)
ES (2) ES2879838T3 (es)
HU (2) HUE054300T2 (es)
MA (1) MA46548B1 (es)
MX (1) MX2017010883A (es)
PL (2) PL3283097T3 (es)
PT (2) PT3283097T (es)
RU (1) RU2704252C2 (es)
SI (2) SI3283097T1 (es)
WO (1) WO2016166288A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3237608B1 (en) * 2014-12-22 2019-10-09 F. Hoffmann-La Roche AG Cmp-dependent sialidase activity
ES2879838T3 (es) 2015-04-17 2021-11-23 Ferring Bv Composición que comprende FSH para el tratamiento de la esterilidad
HUE068024T2 (hu) * 2017-09-01 2024-12-28 Ferring Bv Szabályozott petefészek-stimulálására szolgáló készítmény
HRP20250452T1 (hr) * 2018-04-30 2025-06-06 Ferring B.V. Pripravak za kontroliranu stimulaciju jajnika
KR20210033995A (ko) 2018-06-22 2021-03-29 큐진 인크. 인터루킨-2 변이체 및 이의 사용 방법
TWI846743B (zh) 2018-10-17 2024-07-01 荷蘭商菲林公司 用於控制性卵巢刺激之組成物及方法
TW202237173A (zh) * 2020-12-09 2022-10-01 荷蘭商菲林公司 用於受控的卵巢刺激之組成物及方法
EP4504236A1 (en) * 2022-04-01 2025-02-12 Ferring B.V. Mixed protocol for treatment of infertility

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1228973B (de) * 1961-05-13 1966-11-17 Skf Kugellagerfabriken Gmbh Streckwerk fuer Spinnereimaschinen
US8173592B1 (en) * 1999-03-31 2012-05-08 Zentaris Ivf Gmbh Method for a programmed controlled ovarian stimulation protocol
TWI488640B (zh) 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
JO3092B1 (ar) 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض
ES2879838T3 (es) 2015-04-17 2021-11-23 Ferring Bv Composición que comprende FSH para el tratamiento de la esterilidad

Also Published As

Publication number Publication date
KR20170137041A (ko) 2017-12-12
EP3662925B1 (en) 2021-04-07
HUE048757T2 (hu) 2020-08-28
US11439686B2 (en) 2022-09-13
EP3662925A1 (en) 2020-06-10
PL3662925T3 (pl) 2021-10-25
US20180125942A1 (en) 2018-05-10
PT3662925T (pt) 2021-07-01
US10660938B2 (en) 2020-05-26
DK3662925T3 (da) 2021-06-28
SI3283097T1 (sl) 2020-06-30
RU2704252C2 (ru) 2019-10-25
US20230139407A1 (en) 2023-05-04
CN107405385A (zh) 2017-11-28
JP2018513161A (ja) 2018-05-24
JP7161511B2 (ja) 2022-10-26
MA46548B1 (fr) 2020-03-31
KR20240073153A (ko) 2024-05-24
AU2016247498B2 (en) 2021-06-03
ES2879838T3 (es) 2021-11-23
SI3662925T1 (sl) 2021-08-31
EP3283097A1 (en) 2018-02-21
ES2784625T3 (es) 2020-09-29
DK3283097T3 (da) 2020-04-20
HUE054300T2 (hu) 2021-08-30
PT3283097T (pt) 2020-04-06
EP3283097B1 (en) 2020-02-12
MA46548A (fr) 2018-02-21
RU2017128296A3 (es) 2019-06-25
JP2021020915A (ja) 2021-02-18
PL3283097T3 (pl) 2020-10-19
CA2975444A1 (en) 2016-10-20
US20200353053A1 (en) 2020-11-12
JP7079094B2 (ja) 2022-06-01
AU2016247498A1 (en) 2017-08-17
RU2017128296A (ru) 2019-05-17
WO2016166288A1 (en) 2016-10-20

Similar Documents

Publication Publication Date Title
MX2021000710A (es) Composiciones que comprenden cepas bacterianas.
MX2019003623A (es) Composiciones y metodos para el tratamiento de afecciones oftalmicas.
MX2019007021A (es) Anticuerpos il-11ra.
MY191581A (en) Anti-pd-1 antibodies
MX2020014120A (es) Agonistas parciales del receptor de insulina.
MX2017010883A (es) Composicion para el tratamiento de la infertilidad.
MX2018005315A (es) Composiciones y metodos para el tratamiento del cancer.
CY1117214T1 (el) Συνθεση για ελεγχομενη διεγερση των ωοθηκων
MX2017003478A (es) Anticuerpos anti-fgfr2/3 y metodos para su uso.
SG10201803042PA (en) Anti-tim-3 antibodies
GB2541571A (en) Pharmaceutical compositions
MY192927A (en) Fused bicyclic compounds for the treatment of disease
MX2018009325A (es) Compuestos y metodos para tratar enfermedades mediadas por el acido ribonucleico (arn).
MX2017008456A (es) Compuestos biciclicos fusionados para el tratamiento de enfermedades.
MY191539A (en) Streptococcal vaccine
LT3380508T (lt) Termostabilus fgf2 polipeptidas, jo panaudojimas
MX2018000715A (es) Metodos para tratar cancer usando apilimod.
MX2018000395A (es) Proteinas y composiciones inmunizantes que contienen proteinas de klebsiella y metodos de uso.
MX2017008390A (es) Uretanos funcionalizados con alcoxisilano y funcionalizados con alofanato.
MX2017007953A (es) Tratamiento de la degeneración de la retina mediante el uso de células progenitoras.
PH12017501864A1 (en) Compositions and methods for treating autism
PH12017500602A1 (en) Methods for treating ocular conditions
MX382092B (es) Compuestos heterocíclicos para el tratamiento de enfermedades.
MX370897B (es) Compuestos bicíclicos fusionados para el tratamiento de enfermedades,
EP4541423A3 (en) Dosing regimen of avelumab for the treatment of cancer